本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Taysha Gene Therapies, Inc.

2.19
+0.08504.05%
成交量:47.43萬
成交額:103.00萬
市值:4.48億
市盈率:-6.12
高:2.22
開:2.09
低:2.07
收:2.10
資料載入中...
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

重要事件披露

Form 8-K - Current report
2023/12/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/20

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/09/26

重要事件披露

Form 8-K - Current report
2023/09/19

重要事件披露

Form 8-K - Current report
2023/09/07

SEC問詢函

Form CORRESP - Correspondence
2023/08/29

重要事件披露

Form 8-K - Current report
2023/08/28

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals